The number of people with susceptibility test result for rifampicin in Kazakhstan
Kazakhstan: The number of people with susceptibility test result for rifampicin was 99.88 in 2021. ▲ Rising
Latest (2021)
99.88
Change on year
down 0.0%
World rank
32nd
of 146 countries
All-time high
99.92
in 2020
All-time low
55.67
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Kazakhstan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Kazakhstan is 99.88, measured in 2021.
That represents a change of up 79.4% over five years.
Kazakhstan ranks 32nd of 146 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Kazakhstan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 55.67 | — |
| 2018 | 93.73 | +68.4% |
| 2019 | 98.24 | +4.8% |
| 2020 | 99.92 | +1.7% |
| 2021 | 99.88 | -0.0% |
Kazakhstan compared with similar countries
- Kazakhstan's 99.88 is above the median for upper middle income countries, which is 92.7, 1.1× the median. (45 countries reporting)
- Kazakhstan's 99.88 is above the median for Europe & Central Asia, which is 93.52, 1.1× the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 82.55 | 55.67 | 98.24 | 3 |
| 2020s | 99.9 | 99.88 | 99.92 | 2 |
Countries ranked near Kazakhstan
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0485 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Kazakhstan?
- The number of people with susceptibility test result for rifampicin in Kazakhstan was 99.88 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Kazakhstan?
- The highest recorded value was 99.92 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Kazakhstan?
- The lowest recorded value was 55.67 in 2017.
- How does Kazakhstan rank for the number of people with susceptibility test result for rifampicin?
- Kazakhstan ranks 32nd out of 146 countries with data for 2021.
- Where does this Kazakhstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).